Retour
Fourchette du Jour
1,55 €
2,05 €
Fourchette 52 Semaines
1,55 €
3,26 €
Volume
1 000
Moyenne 50J / 200J
1,85 €
/
2,64 €
Clôture Précédente
1,55 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -5,3 | 0,4 |
| P/B | 0,3 | 2,9 |
| ROE % | -6,4 | 3,8 |
| Net Margin % | -43,7 | 3,9 |
| Rev Growth 5Y % | 421,6 | 10,0 |
| D/E | 0,2 | 0,2 |
Points Clés
Revenue grew 421,58% annually over 5 years — strong growth
Debt/Equity of 0,19 — conservative balance sheet
Negative free cash flow of -443,78M
Revenue growth is decelerating — 1Y growth trails 5Y average by 384,90%
Capital efficient — spends only 7,75% of revenue on capex
Croissance
Revenue Growth (5Y)
421,58%
Revenue (1Y)36,68%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-6,35%
ROIC-4,93%
Net Margin-43,65%
Op. Margin-52,09%
Sécurité
Debt / Equity
0,19
Current Ratio7,37
Interest Coverage-15,56
Valorisation
P/E Ratio
-5,25
P/B Ratio0,34
EV/EBITDAN/A
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 36,68% | Revenue Growth (3Y) | 27,05% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 421,58% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,01B | Net Income (TTM) | -440,63M |
| ROE | -6,35% | ROA | -4,68% |
| Gross Margin | 86,29% | Operating Margin | -52,09% |
| Net Margin | -43,65% | Free Cash Flow (TTM) | -443,78M |
| ROIC | -4,93% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,19 | Current Ratio | 7,37 |
| Interest Coverage | -15,56 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | -5,25 | P/B Ratio | 0,34 |
| P/S Ratio | 2,29 | PEG Ratio | 3,07 |
| EV/EBITDA | N/A | Dividend Yield | 0,01% |
| Market Cap | 2,32B | Enterprise Value | -2,64B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 1,01B | 738,54M | 625,40M | 1,04B | 1,36M |
| Net Income | -440,63M | -631,26M | -886,59M | -64,55M | -391,40M |
| EPS (Diluted) | -0,26 | -0,37 | -0,60 | -0,04 | -0,40 |
| Gross Profit | 871,01M | 610,10M | 482,01M | 977,37M | 1,36M |
| Operating Income | -525,78M | -651,15M | -770,40M | -181,10M | -558,99M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 9,41B | 9,92B | 10,32B | 7,40B | 4,54B |
| Total Liabilities | 2,66B | 2,74B | 2,68B | 1,74B | 1,38B |
| Shareholders' Equity | 6,73B | 7,15B | 7,60B | 5,60B | 3,10B |
| Total Debt | 1,27B | 1,35B | 1,25B | 1,27B | 1,17B |
| Cash & Equivalents | 6,22B | 8,22B | 8,70B | 5,93B | 3,97B |
| Current Assets | 7,82B | 8,77B | 9,30B | 6,42B | 4,09B |
| Current Liabilities | 1,06B | 2,09B | 2,08B | 329,30M | 104,45M |